Liver Transplant for Cholangiocarcinoma

Daniel Zamora-Valdes, Julie K. Heimbach

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Liver transplant (LT) for perihilar cholangiocarcinoma (CCA) offers an opportunity for survival among patients with early-stage but anatomically unresectable disease. The 5-year survival rate after LT is 65% to 70%, higher among patients with primary sclerosing cholangitis, who are often diagnosed earlier, and lower among patients with de novo CCA. The results of LT for hilar CCA, along with recent limited data suggesting favorable survival among patients with very early intrahepatic CCA (ICC), have reignited interest in the subject. This article discusses LT following neoadjuvant therapy for CCA and the early data on LT alone for ICC.

Original languageEnglish (US)
Pages (from-to)267-280
Number of pages14
JournalGastroenterology Clinics of North America
Issue number2
StatePublished - Jun 2018


  • Hilar cholangiocarcinoma
  • Intrahepatic cholangiocarcinoma
  • Liver cancer
  • Liver transplantation
  • Neoadjuvant radiotherapy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Liver Transplant for Cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this